Matches in Wikidata for { <http://www.wikidata.org/entity/Q98629979> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q98629979 description "article scientifique publié en 2020" @default.
- Q98629979 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98629979 description "scientific article published on 20 August 2020" @default.
- Q98629979 description "wetenschappelijk artikel" @default.
- Q98629979 description "наукова стаття, опублікована 20 серпня 2020" @default.
- Q98629979 name "Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer" @default.
- Q98629979 name "Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer" @default.
- Q98629979 type Item @default.
- Q98629979 label "Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer" @default.
- Q98629979 label "Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer" @default.
- Q98629979 prefLabel "Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer" @default.
- Q98629979 prefLabel "Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer" @default.
- Q98629979 P1433 Q98629979-39E450FA-5C0D-408A-BA42-79F896BAE8F3 @default.
- Q98629979 P1476 Q98629979-88CA9201-AB40-41FA-BDE4-3F211D3E4B6D @default.
- Q98629979 P2093 Q98629979-1BFF801F-A0D9-48BF-AD5C-EBE1B27C228C @default.
- Q98629979 P2093 Q98629979-237B8321-1941-4A08-8EB2-0B9E59E307A6 @default.
- Q98629979 P2093 Q98629979-2CB2BE3B-65A0-4257-9C32-32714B176C9C @default.
- Q98629979 P2093 Q98629979-48ED3688-1E66-4187-B85E-68BF856AED1E @default.
- Q98629979 P2093 Q98629979-4E7AB105-8830-4D02-8A2A-B9DDD4655A79 @default.
- Q98629979 P2093 Q98629979-AE982B75-A22D-44AF-A28C-661636D3F07C @default.
- Q98629979 P2093 Q98629979-B22BE3AF-46B5-4A51-A726-3965D3B2B171 @default.
- Q98629979 P2093 Q98629979-B94569B7-FA4A-49A0-9802-77E54361224D @default.
- Q98629979 P2093 Q98629979-BD0D1306-12F1-42F1-82C3-1B4CCBA36B22 @default.
- Q98629979 P2093 Q98629979-F73A56D8-184F-4EFB-B5E3-EE395B99E353 @default.
- Q98629979 P2093 Q98629979-F9EF3AC3-AC82-470B-8C85-B7105BDF6072 @default.
- Q98629979 P2860 Q98629979-2CE626A3-0699-496F-A754-0C9141150CD2 @default.
- Q98629979 P2860 Q98629979-6013C7A9-B44D-44FE-BFA8-E44763018624 @default.
- Q98629979 P31 Q98629979-D1A61B82-3A42-4559-9CB2-00E16CFEFAB0 @default.
- Q98629979 P356 Q98629979-A29F794D-7516-40DC-A90E-4045DFBF3D13 @default.
- Q98629979 P577 Q98629979-EE560A53-0A0C-4326-BF4B-8F597931687F @default.
- Q98629979 P698 Q98629979-34D26190-9056-4AB0-9501-672A0EE5E085 @default.
- Q98629979 P356 J.CANLET.2020.08.006 @default.
- Q98629979 P698 32829006 @default.
- Q98629979 P1433 Q326372 @default.
- Q98629979 P1476 "Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer" @default.
- Q98629979 P2093 "Chen-Chen Zhao" @default.
- Q98629979 P2093 "Cong-Jun Zhang" @default.
- Q98629979 P2093 "Kang-Sheng Gu" @default.
- Q98629979 P2093 "Meng-Na Zhan" @default.
- Q98629979 P2093 "Teng-Teng Zhang" @default.
- Q98629979 P2093 "Wan-Ting Liu" @default.
- Q98629979 P2093 "Wei Wei" @default.
- Q98629979 P2093 "Yang Jiao" @default.
- Q98629979 P2093 "Yi-Yin Zhang" @default.
- Q98629979 P2093 "Ying-Ying Du" @default.
- Q98629979 P2093 "Yu Lei" @default.
- Q98629979 P2860 Q29547693 @default.
- Q98629979 P2860 Q37854720 @default.
- Q98629979 P31 Q13442814 @default.
- Q98629979 P356 "10.1016/J.CANLET.2020.08.006" @default.
- Q98629979 P577 "2020-08-20T00:00:00Z" @default.
- Q98629979 P698 "32829006" @default.